Skip to main content

Table 1 Patient characteristics at baseline

From: Influence of continuous erythropoietin receptor activator (CERA) administration intervals on erythropoietic effect in hemodialysis patients

CERA dosage (μg/4 weeks)

Male (%)

Age (years)

Diabetes (%)

HD vintage (months)

BUN (mg/dL)

Cr (mg/dL)

TP (g/dL)

Alb (g/dL)

Hb (g/dL)

CRP (mg/dL)

Fe (μg/dL)

Ferritin (ng/mL)

Hepcidin-25 (ng/mL)

50 (N = 25)

16 (64.0)

70.0 ± 11.3 (35–87)

13 (52.0)

105.5 ± 90.6

62.6 ± 13.6

10.7 ± 2.1

6.5 ± 0.5

3.8 ± 0.3

10.9 ± 0.8

0.35 ± 0.53

79.7 ± 26.0 (36–123)

143.2 ± 155.0 (16.1–824)

74.2 ± 41.9 (0.4–175.9)

100 (N = 13)

9 (69.2)

70.6 ± 7.7 (53–85)

4 (30.8)

67.4 ± 66.4

67.5 ± 14.2

10.4 ± 1.9

6.7 ± 0.3

3.7 ± 0.3

11.0 ± 0.7

0.25 ± 0.52

82.1 ± 31.7 (32–145)

89.1 ± 70.4 (25.1–233)

38.9 ± 33.6 (0.2–122)

150 (N = 6)

5 (83.3)

69.0 ± 9.3 (51–75)

5 (83.3)

88.5 ± 45.4

57.9 ± 23.2

9.1 ± 4.0

6.6 ± 0.4

3.3 ± 0.2

10.4 ± 1.0

2.46 ± 3.17

44.8 ± 15.8 (26–68)

128.6 ± 89.6 (54.6–263)

90.2 ± 29.3 (55.7–137.1)

All (N = 44)

30 (68.2)

70.0 ± 9.9 (35–87)

22 (50.0)

91.9 ± 79.6

63.4 ± 15.2

10.4 ± 2.4

6.6 ± 0.4

3.7 ± 0.3

10.9 ± 0.8

0.61 ± 1.40

75.6 ± 29.0 (26–145)

125.2 ± 127.7 (16.1–824)

66.0 ± 41.7 (0.2–175.9)

  1. Variables are represented as mean ± standard deviation
  2. HD hemodialysis, BUN blood urea nitrogen, Cr creatinine, TP total protein, Alb albumin, Hb hemoglobin, CRP C-reactive protein, Fe iron